Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Other Non-Current Assets (2019 - 2025)

AVITA Medical filings provide 7 years of Other Non-Current Assets readings, the most recent being $612000.0 for Q4 2025.

  • On a quarterly basis, Other Non-Current Assets rose 12.09% to $612000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $612000.0, a 12.09% increase, with the full-year FY2025 number at $612000.0, up 12.09% from a year prior.
  • Other Non-Current Assets hit $612000.0 in Q4 2025 for AVITA Medical, down from $1.1 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $1.1 million in Q3 2025 to a low of $122000.0 in Q4 2022.
  • Median Other Non-Current Assets over the past 5 years was $321000.0 (2023), compared with a mean of $409900.0.
  • Biggest five-year swings in Other Non-Current Assets: surged 319.74% in 2021 and later plummeted 80.88% in 2022.
  • AVITA Medical's Other Non-Current Assets stood at $638000.0 in 2021, then plummeted by 80.88% to $122000.0 in 2022, then surged by 190.98% to $355000.0 in 2023, then skyrocketed by 53.8% to $546000.0 in 2024, then increased by 12.09% to $612000.0 in 2025.
  • The last three reported values for Other Non-Current Assets were $612000.0 (Q4 2025), $1.1 million (Q3 2025), and $839000.0 (Q2 2025) per Business Quant data.